NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘OrbiMed’

3 February 2015

OrbiMed closes Royalty Opportunities II on $924m

heart monitor medical healthcare Venture capital firm OrbiMed has closed its second healthcare royalty and credit opportunities Fund on $924m, AltAssets can reveal.

9 January 2015

OrbiMed, Janus join $51.4m Series D for cancer-fighting Aduro Biotech

syringe-m Venture capital investors Orbimed and Janus Capital Management are among new investors backing a hefty $51.4m Series D round of financing for cancer-researching biotech company Aduro Biotech.

3 December 2014

Venture-backed gene therapy business Audentes nets $42.5m Series B

Audentes A string of venture capital firms have taken part in a $42.5m Series B financing round for gene therapy business Audentes Therapeutics.

1 December 2014

Growth hormone deficiency treatment company Ascendis picks up $60m VC-backed Series D

drug tablet pill medical pharma Sofinnova Ventures has joined with OrbiMed and Vivo Capital to lead a $60m Series D financing round for biotech business Ascendis Pharma.

27 November 2014

German life science firm Pieris lands £6.6m

teladoc Private equity firm Ally Bridge Group has made its first venture capital investment in Germany by participating in the €6.6m financing round in life sciences firm Pieris.

16 October 2014

OrbiMed, Frontline BioVentures back $51m retina surgery device business MID

MID Labs OrbiMed and Frontline BioVentures have led a $51m financing round for medical device business MID Labs, which focuses on products for retina surgery.

18 July 2014

Roka Bioscience raised $60m via Nasdaq IPO

biotech Venture capital-backed molecular diagnostics specialist Roka Bioscience has raised $60m via an IPO on the Nasdaq exchange.

30 May 2014

KPCB, OrbiMed, DAG renew commitment to ARMO BioSciences in $30m Series B

medical cell disease virus health A trio of venture capital investors have reaffirmed their commitment to ARMO BioSciences by backing a $30m Series B financing round.

23 April 2014

OrbiMed leads $22m round for Aerpio Therapeutics

biotech_lrg Biopharmaceutical startup Aerpio Therapeutics has secured $22m in a round led by venture capital firm OrbiMed.

10 March 2014

Healthcare developer Domain Surgical scores $35m investment round

Domain Surgical, a developer of advanced thermal surgical technology, has closed a $35m equity and debt financing round led by healthcare-focused investment firm OrbiMed.

Page 1 of 212

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015